Highgate Hill, Australia

Irene Chassagnon

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Beijing University of Technology, The University of Queensland. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irene Chassagnon. Retrieved from https://idiyas.com/inventor/irene-chassagnon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Irene Chassagnon

Introduction

Irene Chassagnon is a notable inventor based in Highgate Hill, Australia. She has made significant contributions to the field of neuroprotective agents, particularly through her research involving spider venom peptides. With a total of two patents to her name, her work is paving the way for advancements in neuroprotection.

Latest Patents

Chassagnon's latest patents focus on neuroprotective agents derived from spider venom peptides. These inventions relate to disulfide-rich peptides that have potential applications as neuroprotective agents. Additionally, her patents encompass nucleic acid molecules encoding these peptides, as well as constructs and host cells that incorporate those nucleic acid molecules.

Career Highlights

Throughout her career, Irene has worked with prestigious institutions such as the University of Queensland and Beijing University of Technology. Her research has garnered attention for its innovative approach to neuroprotection, showcasing her expertise in the field.

Collaborations

Irene has collaborated with notable individuals in her field, including Glenn King and Lachlan Douglas Rash. These partnerships have contributed to her research and the development of her patents.

Conclusion

Irene Chassagnon is a pioneering inventor whose work on neuroprotective agents derived from spider venom peptides is making a significant impact in the field of neuroscience. Her contributions highlight the importance of innovation in developing new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…